Tempus AI is a technology company at the forefront of advancing precision medicine through the practical application of artificial intelligence in healthcare. By building the world's largest library of clinical and molecular data, coupled with an operating system to make that data accessible and useful, Tempus enables physicians to make real-time, data-driven decisions to personalize patient care and researchers to accelerate the discovery, development, and delivery of new therapeutics. Their platform focuses on areas like oncology, neurology, cardiology, and infectious diseases, aiming to improve patient outcomes and streamline the healthcare ecosystem.
Serves as the central hub for research and development, data science, engineering, CAP/CLIA-certified laboratory operations, and corporate functions.
Located in the historic former Montgomery Ward Catalog House, a landmark building on the Chicago River, renovated to support a modern tech and biotech workspace with state-of-the-art lab facilities.
A dynamic, innovative, and collaborative environment focused on leveraging AI to advance precision medicine. Employees are mission-driven, working on cutting-edge projects in a fast-paced setting that encourages learning and growth.
Chicago provides access to a rich talent pool from renowned universities, a burgeoning tech scene, and proximity to major healthcare institutions and research facilities, fostering collaboration and innovation.
Tempus AI primarily operates across North America with key lab and office locations in the United States. The company is actively expanding its international presence, with a notable office in London, UK, to support European operations. Its data and AI platform supports research collaborations and clinical decision support globally, aiming to make precision medicine accessible worldwide. Functions supported globally include data acquisition, AI model development, research partnerships, and providing insights to clinicians and pharmaceutical companies.
600 West Chicago Avenue, Suite 510
Chicago
IL
USA
Address: 345 Allerton Ave, South San Francisco, CA 94080 (Lab Facility)
Key West Coast hub for R&D, lab services, and collaborations with tech and biotech partners in Silicon Valley.
Address: Durham, NC (Specific address varies by facility within RTP)
Supports East Coast operations, R&D, and lab services, enhancing capacity for genomic testing and data analysis.
Address: Manhattan, New York, NY (Office)
Strategic presence for engaging with key stakeholders in finance, pharmaceuticals, and major healthcare networks.
Address: Cambridge/Boston Area, MA (Office)
Facilitates cutting-edge research and development, tapping into one of the world's leading biotech clusters.
Address: London (Office)
Expanding Tempus's global footprint and making its precision medicine platform accessible to patients and researchers in Europe.
Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.
As of April 2025, Tempus AI' leadership includes:
Tempus AI has been backed by several prominent investors over the years, including:
Tempus AI has strategically strengthened its executive team over the past 12-18 months with key appointments in finance, commercial operations, and human resources, reflecting its rapid growth, focus on commercialization, and preparation for further expansion. These changes underscore the company's commitment to scaling its operations and impact in precision medicine.
Discover the tools Tempus AI uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.
Tempus AI commonly uses the email format of first initial followed by the last name. While variations might exist, this is a frequently observed pattern for company communications.
flast@tempus.com or first.last@tempus.com
Format
jdoe@tempus.com or john.doe@tempus.com
Example
85%
Success rate
Tempus Press Release / Major Financial News Outlets • May 21, 2024
Tempus AI, Inc. announced that it has publicly filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission (SEC) relating to a proposed initial public offering (IPO) of its Class A common stock. The number of shares to be offered and the price range for the proposed offering have not yet been determined....more
Tempus Press Release • February 7, 2024
Tempus and GSK announced a new collaboration that will leverage Tempus' AI-enabled platform and de-identified data library to enhance GSK's clinical trial design, accelerate enrollment, and identify drug targets. This multi-year agreement aims to improve the efficiency and precision of GSK's R&D....more
Tempus Press Release • March 12, 2024
Tempus and researchers from the University of Chicago published a study in a leading medical journal detailing the discovery of novel genomic and transcriptomic biomarkers that may predict patient response to immunotherapy in advanced bladder cancer. The findings utilized Tempus's multimodal data and analytical capabilities....more
See where a company’s workforce is located, by country or region.
View past and recent funding rounds with amounts and investors.
Understand company revenue estimates and financial scale.
Track active roles and hiring trends to spot growth signals.
Discover what a company offers—products, platforms, and solutions.
Get the company’s official SIC and NAICS classifications.
Analyze visitor volume, engagement, and top traffic sources.
Explore LinkedIn, Twitter, and other active social profiles.
Identify top competitors based on similar business traits.
Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.
Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.
Thousands of companies, including Tempus AI, are just a search away.